INVESTOR

Analyst Coverage

Cardiome Pharma Corp. is covered by the following analysts:

Bear Stearns

Mark Schoenebaum

Leerink Swann

Joe Schwartz

Oppenheimer & Co.

Bret Holley, Ph.D.

Rodman & Renshaw

Michael King, Jr.

UBS Securities

Jeff Elliott, Ph.D.

Wachovia Capital Markets

Aaron Reames

Canaccord Adams (Europe)

Karl Keegan

BMO Capital Markets

Christine Charette

Cormark Securities

David Dean, MSc, MBA

Dundee Securities

David Martin, Ph.D., MBA

GMP Securities

Cosme Ordonez, MD, Ph.D.

Macquarie Capital Markets Canada

Stefan Quenneville, CFA

Raymond James

Brian Bapty, Ph.D.

RBC Capital Markets

Philippa Flint

Scotia Capital

John Maletic, MBA, CFA

Versant Partners

Douglas W. Loe, Ph.D., MBA

 

 

Please note that any opinions, estimates or forecasts regarding Cardiome's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cardiome or its management. Cardiome does not by its reference above or distribution imply any endorsement of or concurrence with such opinions, estimates or forecasts..

Print this page